---
$id: https://graph.org.ai/products/commodity/51112019
$type: Product
source: UNSPSC
code: "51112019"
title: "Bosutinib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bosutinib

**UNSPSC Code**: 51112019
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular structure C26H29CL2N5O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier, 5018V4AEZ0 chemically known as 3-quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methyl-1-piperazinyl)propoxy)-, but more commonly known as bosutinib, which bears U.S. National Institutes of Health Compound Identifier 5328940. European Medicines Agency schedules Bosutinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29176. The term BOSUTINIB is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 20, no. 3, 2006, list 56).

